Bayer Healthcare - Animal Health

Go back to homepage


Bayer Healthcare - Animal Health
Financial Details
Total Company Revenue in 2010 $ 12 Bn
Revenue from Animal Health Market in 2010 $ 0.8 Bn
% of revenue from Animal Health in 2010 6.67%
Segmentwise Revenue Breakup ($ Bn)
Livestock Vaccines 0.32
Companion Vaccines 0.48
Number of Major Vaccines (Animal-wise)
Poultry 5
Swine 13
Fish 2
Sheep 1
Cattle 14
Canine 4
Feline 4
Equine 5
Future Focus Areas
Veterinary Vaccines under trial 0
Future Focus Areas of the company in the Veterinary Vaccines Market The Animal Health Division focuses its research and development activities on antimicrobials, parasiticides and active substances useful for the treatment of non-infectious diseases such as renal failure, pain management, oncology, and congestive heart failure
Parasitology and drug delivery systems, chewable drug admisitration technology (cats and dogs); innovative mastitis and reproduction products, injectable solutions and suspensions, intra-ruminal devices, and sheep, cattle and equine parasiticides;

There are no Mergers and Acquisitions by Bayer Healthcare in Veterinary Vaccines segment



Go back to homepage